# Greystone Housing Impact Investors LP: financial statements, quarterly

GHI · NYSE · CIK 1059142 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ghi.md) · [Financials](/companies/ghi/financials.md) · [Filings](/companies/ghi/filings.md) · [Insiders](/companies/ghi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ghi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [26.5](/filings/0000950170-25-023761.md) | [25.2](/filings/0000950170-25-023761.md) | [22.4](/filings/0000950170-25-065080.md) | [22.0](/filings/0000950170-25-104618.md) | [24.3](/filings/0001193125-25-268211.md) | [22.6](/filings/0000950170-25-023761.md) | [24.3](/filings/0001193125-26-216905.md) | [22.8](/filings/0001193125-26-342418.md) | [21.7](/filings/0001193125-25-268211.md) | [15.0 d](/filings/0001193125-26-108471.md) | [21.8](/filings/0001193125-26-216905.md) | [21.2](/filings/0001193125-26-342418.md) |
| Operating income | $m | [9.7](/filings/0000950170-25-023761.md) | [6.2](/filings/0000950170-25-023761.md) | [10.6](/filings/0000950170-25-023761.md) | [5.2](/filings/0000950170-25-023761.md) | [(4.6)](/filings/0000950170-25-023761.md) | [10.1](/filings/0000950170-25-023761.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.0](/filings/0000950170-24-121844.md) | [(0.0) d](/filings/0001193125-26-108471.md) | [(0.0)](/filings/0000950170-25-065080.md) | [(0.0)](/filings/0000950170-25-104618.md) | [(0.0)](/filings/0001193125-25-268211.md) | [0.0 d](/filings/0001193125-26-108471.md) | [(0.0)](/filings/0001193125-26-216905.md) | [(0.0)](/filings/0001193125-26-342418.md) | [(0.0)](/filings/0001193125-25-268211.md) | [0.8 d](/filings/0001193125-26-108471.md) | [(0.0)](/filings/0001193125-26-216905.md) | [(0.0)](/filings/0001193125-26-342418.md) |
| Net income | $m | [9.7](/filings/0000950170-24-121844.md) | [6.2 d](/filings/0001193125-26-108471.md) | [10.6](/filings/0000950170-25-065080.md) | [5.2](/filings/0000950170-25-104618.md) | [(4.6)](/filings/0001193125-25-268211.md) | [10.1 d](/filings/0001193125-26-108471.md) | [2.4](/filings/0001193125-26-216905.md) | [(8.3)](/filings/0001193125-26-342418.md) | [2.0](/filings/0001193125-25-268211.md) | [(5.8) d](/filings/0001193125-26-108471.md) | [1.3](/filings/0001193125-26-216905.md) | [(1.5)](/filings/0001193125-26-342418.md) |
| Diluted EPS | $ per share | [0.39](/filings/0000950170-25-023761.md) | [0.24](/filings/0000950170-25-023761.md) | [0.42](/filings/0000950170-25-065080.md) | [0.19](/filings/0000950170-25-104618.md) | [(0.23)](/filings/0001193125-25-268211.md) | [0.39](/filings/0000950170-25-023761.md) | [0.07](/filings/0001193125-26-216905.md) | [(0.40)](/filings/0001193125-26-342418.md) | [0.03](/filings/0001193125-25-268211.md) | not reported | [0.01](/filings/0001193125-26-216905.md) | [(0.11)](/filings/0001193125-26-342418.md) |
| Basic EPS | $ per share | [0.39](/filings/0000950170-25-023761.md) | [0.24](/filings/0000950170-25-023761.md) | [0.42](/filings/0000950170-25-065080.md) | [0.19](/filings/0000950170-25-104618.md) | [(0.23)](/filings/0001193125-25-268211.md) | [0.39](/filings/0000950170-25-023761.md) | [0.07](/filings/0001193125-26-216905.md) | [(0.40)](/filings/0001193125-26-342418.md) | [0.03](/filings/0001193125-25-268211.md) | not reported | [0.01](/filings/0001193125-26-216905.md) | [(0.11)](/filings/0001193125-26-342418.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [58.9](/filings/0000950170-24-121844.md) | [37.9](/filings/0001193125-26-108471.md) | [56.3](/filings/0000950170-25-065080.md) | [34.0](/filings/0000950170-25-104618.md) | [37.4](/filings/0001193125-25-268211.md) | [14.7](/filings/0001193125-26-108471.md) | [51.4](/filings/0001193125-26-216905.md) | [47.5](/filings/0001193125-26-342418.md) | [36.2](/filings/0001193125-25-268211.md) | [39.5](/filings/0001193125-26-342418.md) | [20.6](/filings/0001193125-26-216905.md) | [30.9](/filings/0001193125-26-342418.md) |
| Total assets | $m | [1,546](/filings/0000950170-23-060709.md) | [1,513](/filings/0000950170-25-023761.md) | [1,453](/filings/0000950170-24-055101.md) | [1,529](/filings/0000950170-24-092308.md) | [1,549](/filings/0000950170-24-121844.md) | [1,580](/filings/0001193125-26-108471.md) | [1,503](/filings/0001193125-26-216905.md) | [1,481](/filings/0000950170-25-104618.md) | [1,486](/filings/0001193125-25-268211.md) | [1,503](/filings/0001193125-26-342418.md) | [1,487](/filings/0001193125-26-216905.md) | [1,387](/filings/0001193125-26-342418.md) |
| Total liabilities | $m | [1,157](/filings/0000950170-23-060709.md) | [1,082](/filings/0000950170-25-023761.md) | [1,026](/filings/0000950170-24-055101.md) | [1,125](/filings/0000950170-24-092308.md) | [1,142](/filings/0000950170-24-121844.md) | [1,196](/filings/0001193125-26-108471.md) | [1,146](/filings/0000950170-25-065080.md) | [1,104](/filings/0000950170-25-104618.md) | [1,097](/filings/0001193125-25-268211.md) | [1,123](/filings/0001193125-26-342418.md) | [1,118](/filings/0001193125-26-216905.md) | [1,020](/filings/0001193125-26-342418.md) |
| Long-term debt | $m | [26.5](/filings/0000950170-23-060709.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [7.2 d](/filings/0000950170-24-121844.md) | [4.7 d](/filings/0001193125-26-108471.md) | [3.4](/filings/0000950170-25-065080.md) | [5.1 d](/filings/0000950170-25-104618.md) | [4.9 d](/filings/0001193125-25-268211.md) | [4.6 d](/filings/0001193125-26-108471.md) | [11.0](/filings/0001193125-26-216905.md) | [10.5 d](/filings/0001193125-26-342418.md) | [7.4 d](/filings/0001193125-25-268211.md) | [8.6 d](/filings/0001193125-26-108471.md) | [(0.1)](/filings/0001193125-26-216905.md) | [1.2 d](/filings/0001193125-26-342418.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported

Shares outstanding: 23,562,510 at 2026-06-30, from the cover of the [10-Q filed 2026-08-10](/filings/0001193125-26-342418.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.